机构

• 上海药物研究所 [14]
• 过程工程研究所 [9]
• 青海盐湖研究所 [6]
• 昆明植物研究所 [5]
• 金属研究所 [4]
• 植物研究所 [3]
• 更多

采集方式

• OAI收割 [63]
• iSwitch采集 [2]

内容类型

• 期刊论文 [61]
• 会议论文 [3]
• 学位论文 [1]

发表日期

• 2024 [3]
• 2023 [2]
• 2022 [4]
• 2021 [2]
• 2020 [6]
• 2019 [6]
• 更多

学科主题

• Plant Scie... [3]
• Biology [1]
• Oncology [1]
• 材料科学与物理化学 [1]
• 热化学转化 [1]
• 矿物学 [1]
• 更多

筛选

浏览/检索结果: 共65条，第1-10条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择题名升序题名降序提交时间升序提交时间降序作者升序作者降序发表日期升序发表日期降序 A patent review of BRD4 inhibitors (2020-present) 期刊论文  OAI收割 EXPERT OPINION ON THERAPEUTIC PATENTS, 2025, 页码: 16 作者:  Chen, Yanfang;  Zhou, Huanmin;  Yu, Jiamin;  Gao, Jing;  Xue, Shengyu   |  收藏  |  浏览/下载：2/0  |  提交时间：2025/04/01 BET  BRD4  inhibitor  cancer treatment  selectivity   Liver-targeting chimeras as a potential modality for the treatment of liver diseases 期刊论文  OAI收割 JOURNAL OF CONTROLLED RELEASE, 2024, 卷号: 374, 页码: 627-638 作者:  Chen, Chuanjie;  Pan, Yongzhang;  Yang, Xiaoyu;  Li, Huiqin;  Cai, Xinhui   |  收藏  |  浏览/下载：21/0  |  提交时间：2024/10/21 ASGPR  BET  Hepatocellular carcinoma  LIVTAC  On-target toxicity  PROTAC   Co-inhibition of BET and NAE enhances BIM-dependent apoptosis with augmented cancer therapeutic efficacy 期刊论文  OAI收割 BIOCHEMICAL PHARMACOLOGY, 2024, 卷号: 223, 页码: 17 作者:  Zhang, Qian;  Wu, Qian;  Huan, Xia-Juan;  Song, Shan -Shan;  Bao, Xu-Bin   |  收藏  |  浏览/下载：24/0  |  提交时间：2024/06/27 BET inhibitor  NAE inhibitor  BIM  Apoptosis  Combination therapy   Discovery of a brain-permeable bromodomain and extra terminal domain (BET) inhibitor with selectivity for BD1 for the treatment of multiple sclerosis 期刊论文  OAI收割 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 卷号: 265, 页码: 14 作者:  Chen, Xuetao;  Wu, Tingting;  Du, Zhiyan;  Kang, Wenjing;  Xu, Rujun   |  收藏  |  浏览/下载：40/0  |  提交时间：2024/02/27 BET  BD1  Bromodomain  Brain-permeable  Multiple sclerosis   Evolution of pore structure and adsorption-desorption in oil shale formation rocks after compression 期刊论文  OAI收割 ENERGY, 2023, 卷号: 278, 页码: 127913 作者:  Huang XF(黄先富);  Zhao YP(赵亚溥)   |  收藏  |  浏览/下载：16/0  |  提交时间：2023/09/05 Shale oil and shale gas  Adsorption -desorption ishotherms  BET specific surface area  Total pore volume  Fractal dimension  Carbon sequestration   Cyclization strategy leads to highly potent Bromodomain and extra-terminal (BET) Bromodomain inhibitors for the treatment of acute liver injury 期刊论文  OAI收割 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 卷号: 247, 页码: 13 作者:  Chen, Chao;  Lu, Tian;  Chen, Panyu;  Li, Zizhou;  Yang, Yaxi   |  收藏  |  浏览/下载：30/0  |  提交时间：2023/04/10 BET Bromodomains  Acute liver injury  Anti-inflammatory activity  Inhibitors  Tetracyclic compounds   Design and development of a novel series of oral bivalent BET inhibitors with potent anticancer activities 期刊论文  OAI收割 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 卷号: 239, 页码: 13 作者:  Luo, Menglan;  Wu, Qian;  Yang, Yueyue;  Sun, Lin;  Huan, Xiajuan   |  收藏  |  浏览/下载：57/0  |  提交时间：2022/08/30 BET inhibitor  BRD4  Bivalent inhibitor  Anticancer   Selective bromodomain and extra-terminal bromodomain inhibitor inactivates macrophages and hepatic stellate cells to inhibit liver inflammation and fibrosis 期刊论文  OAI收割 BIOENGINEERED, 2022, 卷号: 13, 期号: 4, 页码: 10914-10930 作者:  Fu, Rong;  Zu, Shi-Jia;  Liu, Yan-Jun;  Li, Jia-Cheng;  Dang, Wen-Zhen   |  收藏  |  浏览/下载：45/0  |  提交时间：2022/06/15 BET inhibitor  macrophage  hepatic stellate cell  inflammation  fibrosis   Repressing MYC by targeting BET synergizes with selective inhibition of PI3K alpha against B cell lymphoma 期刊论文  OAI收割 CANCER LETTERS, 2022, 卷号: 524, 页码: 206-218 作者:  Chen, Zi-qi;  Cao, Zhe-rui;  Wang, Yi;  Zhang, Xi;  Xu, Lan   |  收藏  |  浏览/下载：73/0  |  提交时间：2021/12/16 CYH33  MYC  P300  BET  B cell lymphoma  PI3K   TNKS inhibitors potentiate proliferative inhibition of BET inhibitors via reducing beta-Catenin in colorectal cancer cells 期刊论文  OAI收割 AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 卷号: 12, 期号: 3, 页码: 1069-+ 作者:  Wu, Qian;  Xuan, Yi-Fei;  Su, Ai-Ling;  Bao, Xu-Bin;  Miao, Ze-Hong   |  收藏  |  浏览/下载：44/0  |  提交时间：2022/06/15 BET inhibitor  Tankyrases inhibitor  beta-Catenin  antitumor activity  combination therapy